Home
Contact
Sitemap
Santen Worldwide
HOME
About Santen
News
Investor Relations
Products
Careers
News Releases
News Releases
2008
2007
2006
2005
2004
2003
2002
2008
May 8, 2008
Santen Announces Financial Results for the Year ended March 31, 2008
May 7, 2008
Santen Oy Receives Marketing Authorization for its Glaucoma and Ocular Hypertension Treatment, TAFLOTAN® in Denmark
Mar 26, 2008
Notice Regarding the Completion of Purchase of the Company's Own Shares in the Market
Mar 6, 2008
Notice Regarding the Purchase of the Company's Own Shares in the Market
Feb 25, 2008
Santen to Lift Condition for Approval of PAPILOCK Mini Ophthalmic Solution 0.1%
Jan 30, 2008
Santen to Purchase Own Shares
Jan 30, 2008
Santen Announces Financial Result for the Third Quarter ended December 31, 2007 Appendix
Jan 11, 2008
Santen to Launch Nutritional Supplement Sante Lutax
Back to top
Download Adobe® Reader® to view PDF files.
